Psychiatry and Neurology, Neurology · Atlanta, GA
NPI
1942316815
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1841 Clifton Rd
Atlanta, GA, 30322
Phone (404) 778-3444
Groups this clinician bills Medicare through
Medicare paid, 2024
$94K
8,949 services
Medicare patients, 2024
208
Average age 76
Drug cost, 2024
$1.1M
2,816 prescriptions
Company payments, 2025
$54K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stewart A Factor was code J0585 (injection, onabotulinumtoxina, 1 unit), 6,752 times for 25 patients. In total Stewart A Factor billed 8,949 services in 19 codes, and Medicare paid $94K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 6,752 | 25 | $4.76 | $32K |
| J0587 Injection, rimabotulinumtoxinb, 100 units | Office | 1,334 | 19 | $9.89 | $13K |
| 99215 Office E&M - Established | Office | 195 | 124 | $121.58 | $24K |
| 99214 Office E&M - Established | Office | 87 | 68 | $76.53 | $6,658 |
| 64611 Musculoskeletal | Office | 51 | 18 | $94.30 | $4,809 |
| 64612 Musculoskeletal | Office | 31 | 13 | $123.48 | $3,828 |
| 95874 Musculoskeletal | Office | 25 | 13 | $47.13 | $1,178 |
| 64616 Musculoskeletal | Office | 24 | 12 | $116.52 | $2,797 |
| 99205 Office E&M - New | Office | 17 | 17 | $134.14 | $2,280 |
By year: 2022 $140K for 15,093 services; 2023 $146K for 16,264 services; 2024 $94K for 8,949 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stewart A Factor prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 652 prescriptions and refills. In total Stewart A Factor wrote 2,816 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 652 | 1,471 | 191 | $37K |
| Donepezil Hcl Generic | 230 | 458 | 62 | $2,126 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 213 | 484 | 64 | $7,912 |
| Entacapone Generic | 153 | 287 | 39 | $32K |
| Clonazepam Generic | 113 | 147 | 18 | $544 |
| Amantadine Amantadine Hcl | 99 | 220 | 32 | $5,472 |
| Escitalopram Oxalate Generic | 97 | 221 | 29 | $862 |
| Mirtazapine Generic | 86 | 190 | 27 | $2,521 |
| Gabapentin Generic | 83 | 186 | 29 | $3,140 |
| Quetiapine Fumarate Generic | 78 | 144 | 23 | $1,213 |
| Myrbetriq Mirabegron | 63 | 74 | 12 | $33K |
| Rytary Carbidopa/Levodopa | 51 | 97 | Under 11 | $102K |
| Sertraline Hcl Generic | 48 | 120 | 15 | $440 |
| Lorazepam Generic | 41 | 43 | Under 11 | $581 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 39 | 69 | Under 11 | $260 |
Brand drugs: 244 claims; generic drugs: 2,572 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stewart A Factor $54K ($54K in general payments such as food, travel and fees) from 2 companies. The largest payer was Neurocrine BioSciences, Inc. with $52K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.